Nanobiotix S.A. (NBTX)
NASDAQ·Healthcare·Biotechnology
$35.27
-0.18%
Mkt Cap $1.94B
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$26.00
Range $26.00 – $26.00
Implied Upside
-26.3%
Consensus $26.00 vs current $35.27
NASDAQ·Healthcare·Biotechnology
$35.27
-0.18%
Mkt Cap $1.94B
No recent rating data.
Price Target (3 analysts)
$26.00
Range $26.00 – $26.00
-26.3%
Consensus $26.00 vs current $35.27